Source:http://linkedlifedata.com/resource/pubmed/id/19652213
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
8
|
pubmed:dateCreated |
2009-8-4
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0161-5505
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
50
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
26N-8N
|
pubmed:meshHeading |
pubmed-meshheading:19652213-Drug Approval,
pubmed-meshheading:19652213-Drug Compounding,
pubmed-meshheading:19652213-Drug Industry,
pubmed-meshheading:19652213-Positron-Emission Tomography,
pubmed-meshheading:19652213-Radiopharmaceuticals,
pubmed-meshheading:19652213-United States,
pubmed-meshheading:19652213-United States Food and Drug Administration
|
pubmed:year |
2009
|
pubmed:articleTitle |
Current good manufacturing practices for PET drug products in the United States.
|
pubmed:affiliation |
University of Pittsburgh, Pittsburgh, PA, USA.
|
pubmed:publicationType |
Journal Article
|